Los Angeles, CA., Oct. 27, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer is pleased to announce the launch of the Draganfly Vital Intelligence API integration for telehealth applications.
The API enables telehealth applications to access the Vital Intelligence technology which will enable such applications to measure heart rate, respiratory rate and SPO2.
The Vital Intelligence technology supports kiosks, entry systems, hand-held devices, drones, robots and other edge computing scenarios. With a deployment time of as little as a week, API subscribers will be able to rapidly transform their existing applications without significant retooling of their existing solutions.
Draganfly’s Vital Intelligence Smart Thermal + Vital Assessment Station and Social Distancing Awareness technology provides a quick, non-invasive (contactless) and anonymous measurement of an elevated body temperature, heart rate, respiratory rate, all from a camera that takes seconds to capture. The platform does not register any personal data of the individual being screened.
The new API integration addresses two major challenges for development teams:
- The integrator does not need to work with thermal cameras, signal processing or screening processes. Draganfly’s system manages the entire process automatically.
- The Web based API is accessible to all common operating systems and development environments.
The Vital Intelligence API integration offers best in class workflows, security and reporting utilizing a pre-built interface that can be white-labelled and directly integrated into any technology stack.
“The API captures our experience about how a system like this can be used. It was designed to allow third party software to gain access to the capabilities of our range of vital signs solutions,” said Professor Javaan Chahl, Defense Science and Technology Chair at the University of South Australia and Draganfly’s Chief Scientist for the project. “This screening and monitoring technology can now be integrated rapidly in this dynamic environment”.
“Our new API integration is a true innovation accelerator for the telehealth industry,” said Cameron Chell, CEO of Draganfly. “By enabling our technology via an API integration, telehealth organizations will be able to add an additional layer of testing to their own technology eliminating developer time and increasing product innovation. In addition, the time and cost savings will enable customers to quickly adopt our technology with their existing applications which will extend their ecosystem of customers.”
Draganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge software and systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.
For more information on Draganfly, please visit us at www.draganfly.com.
For additional investor information, visit https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.otcmarkets.com/stock/DFLYF/overview or https://www.boerse-frankfurt.de/aktie/draganfly-inc.
email: [email protected]
Email: [email protected]
This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements include, but are not limited to, statements with respect the successful integration of the Draganfly Vital Intelligence API. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the current outbreak of the novel coronavirus known as COVID-19 on the Company’s business, operations and financial condition, the successful integration of technology, the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties disclosed under the heading “Risk Factors“ in the Company’s most recent filings filed with securities regulators in Canada on the SEDAR website at www.sedar.com. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.